封面
市場調查報告書
商品編碼
1737116

2026 年至 2032 年脊椎移植和手術器械市場(按類型、產品、技術和地區)

Spinal Implants And Surgery Devices Market By Type, By Product, By Technology, And Region for 2026-2032

出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2026-2032年脊椎移植和手術器械市場評估

脊椎疾病發生率的上升、對微創手術的需求以及手術技術的進步是推動脊椎移植和手術器械市場發展的主要因素。根據 Verified Market Research 分析師預測,到 2032 年,脊椎移植和手術器械市場規模將達到 165.7 億美元,低於 2024 年的約 122.1 億美元。

醫療保健成本的上升,特別是在獲得現代治療的機會不斷改善的開發中國家,正在推動對脊椎移植和手術器械的需求,這將推動市場在 2026 年至 2032 年期間以 4.3% 的複合年成長率成長。

脊椎移植和手術器械市場定義/概述

脊椎移植和手術器械是外科醫生用來治療各種脊椎疾病(包括畸形、不穩定和退化性疾病)的專用醫療設備。這些器械對於穩定和強化脊椎、實現脊椎脊椎融合以及治療退化性椎間盤疾病、脊椎側彎、脊椎後凸和骨折等疾病至關重要。脊椎移植可用於融合手術(使用棒和螺釘等器械將脊椎骨融合在一起)和非融合手術(在矯正排列問題的同時保持脊椎運動)。使用這些植入可以改善手術效果,縮短復原時間,並提高患者的整體生活品質。

我們的報告包含可操作的數據和前瞻性的分析,可協助您制定宣傳方案、建立商業計劃、組織簡報或撰寫提案。

影響脊椎移植和外科手術器械市場成長的市場促進因素有哪些?

脊椎疾病和退化性椎間盤疾病發生率的上升正在推動市場擴張。根據世界衛生組織 (WHO) 的報告,預計到 2023 年,全球將有約 6.19 億人受到下背部疼痛的影響,並成為殘疾的主要原因。根據美國神經疾病和中風研究所 (NINDS) 的數據,超過 80% 的成年人在一生中的某個階段會經歷下背部疼痛,約 20% 的人會發展為需要手術干預的慢性疾病。

人口老化日益加劇,對脊椎手術和植入的需求龐大。根據聯合國經濟社會事務部統計,預計2050年,全球65歲以上人口將達15億人。美國神經外科醫師協會(AANS)的數據顯示,脊椎狹窄症主要影響60歲以上的人群,其發生率在過去十年中上升了30%,每年約有25萬至50萬美國人出現嚴重症狀,需要手術干預。

此外,交通事故和體育活動導​​致的脊髓損傷數量不斷增加也推動了市場擴張。根據美國國家脊髓損傷統計中心 (NSCISC) 的數據,光是在美國,每年就有約 17,810 例新的脊髓損傷病例。根據美國疾病管制與預防中心 (CDC) 的數據,機動車事故佔脊髓損傷的 38.6%,其次是跌倒(32.2%)和運動傷害(8.7%),這導致對脊椎移植和手術器械的需求持續穩定。

脊椎移植和手術器械市場面臨的主要挑戰是什麼?

高昂的手術費用是脊椎移植市場發展的主要障礙。脊椎移植手術費用高昂,給患者和醫療保健系統都帶來了巨大的壓力。高成本阻礙了患者接受這項重要治療,從而限制了市場的成長。此外,高昂的價格負擔也促使保險公司對承保範圍進行嚴格審查,使這些重要醫療設備的取得更加複雜。

此外,人們對脊椎健康和治療方案的認知和教育不足也阻礙了市場的成長。許多潛在患者不了解脊椎移植的益處,並對外科手術有誤解。這種認知不足導致脊椎手術方案的使用率不足,影響了醫療保健產業對脊椎移植和器械的整體需求。

目錄

第1章全球脊椎移植和手術器械市場介紹

  • 市場概覽
  • 研究範圍
  • 先決條件

第2章執行摘要

第3章:已驗證的市場研究調查方法

  • 資料探勘
  • 驗證
  • 第一手資料
  • 資料來源列表

第4章全球脊椎移植與手術器械市場展望

  • 概述
  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 波特五力模型
  • 價值鏈分析

第5章全球脊椎移植和手術器械市場(按類型)

  • 概述
  • 開放性手術
  • 微創手術

第6章全球脊椎移植和手術器械市場(按產品)

  • 概述
  • 脊椎固定器
  • 脊椎生技藥品
  • 椎體壓迫性骨折治療裝置
  • 非融合器械
  • 脊椎骨生長刺激器

第7章全球脊椎移植和手術器械市場(按技術)

  • 概述
  • 脊椎融合/融合技術
  • 椎體壓迫性骨折治療
  • 運動保持技術
  • 脊椎減壓手術

第8章全球脊椎移植和手術器械市場(按地區)

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 世界其他地區
    • 拉丁美洲
    • 中東和非洲

第9章全球脊椎移植和手術器械市場的競爭格局

  • 概述
  • 各公司市場排名
  • 主要發展策略

第10章 公司簡介

  • Medtronic
  • DePuy Synthes(Johnson & Johnson)
  • NuVasive, Inc.
  • Stryker Corporation
  • Zimmer Biomet Holdings
  • Globus Medical
  • Abbott
  • RTI Surgical
  • Boston Scientific
  • SeaSpine Holdings Corporation

第11章 附錄

  • 相關調查
簡介目錄
Product Code: 52007

Spinal Implants And Surgery Devices Market Valuation - 2026-2032

The growing incidence of spinal disorders, the need for less invasive procedures, and improvements in surgical techniques are the main factors propelling the Spinal Implants And Surgery Devices Market. According to the analyst from Verified Market Research, the Spinal Implants And Surgery Devices Market is estimated to reach a valuation of USD 16.57 Billion in 2032, by subjugating around USD 12.21 Billion valued in 2024.

The rising healthcare costs, especially in developing nations where access to modern treatments is becoming better, are driving the demand for spinal implants and surgery devices. This demand enables the market to grow at a CAGR of 4.3% from 2026 to 2032.

Spinal Implants And Surgery Devices Market: Definition/Overview

Spinal implants and surgery devices are specialized medical equipment used by surgeons to treat a wide range of spinal disorders, including deformities, instability, and degenerative illnesses. These devices are essential for stabilizing and strengthening the spine, enabling spinal fusion, and addressing conditions such as degenerative disc disease, scoliosis, kyphosis, and fractures. Spinal implants are utilized in fusion procedures, which use devices such as rods and screws to fuse vertebrae, as well as non-fusion treatments, which maintain spinal movement while resolving alignment concerns. The use of these implants improves surgical results, shortens recovery times, and boosts overall patient quality of life.

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

What are the Drivers Influencing the Growth of the Spinal Implants And Surgery Devices Market?

The rising incidence of spinal illnesses and degenerative disc problems is propelling market expansion. The World Health Organization (WHO) reports that low back pain impacted nearly 619 million people worldwide by 2023, making it the largest cause of disability. According to the National Institute of Neurological Disorders and Stroke (NINDS), over 80% of adults have low back pain at some point in their life, with roughly 20% acquiring chronic disorders that necessitate surgical intervention.

The expanding aging population greatly increases the need for spinal surgeries and implants. According to the United Nations Department of Economic and Social Affairs, the global population over the age of 65 is predicted to reach 1.5 billion by 2050. According to the American Association of Neurological Surgeons (AANS), the incidence of spinal stenosis, which primarily affects people over 60, has risen by 30% in the last decade, with approximately 250,000 to 500,000 Americans experiencing symptoms severe enough to necessitate surgical intervention each year.

Furthermore, rising cases of spinal injuries from car accidents and sports activities drive market expansion. According to the National Spinal Cord Injury Statistical Center (NSCISC), approximately 17,810 new spinal cord injury cases occur each year in the United States alone. According to data from the Centers for Disease Control and Prevention (CDC), car crashes account for 38.6% of spine injuries, followed by falls (32.2%) and sports injuries (8.7%), creating a steady demand for spinal implants and surgical devices.

What are the Main Challenges Faced by the Spinal Implants And Surgery Devices Market?

The high cost of procedures is a key obstacle to the spinal implant market. Spinal implant surgeries are costly, putting a strain on both patients and healthcare systems. This high cost discourages patients from pursuing critical therapies, limiting market growth. Furthermore, the price burden prompts heightened scrutiny of coverage by insurance providers, complicating access to these critical medical devices.

Furthermore, limited awareness and education regarding spinal health and treatment choices impede market growth. Many potential patients are unaware of the benefits of spinal implants or have misconceptions regarding surgical procedures. This lack of awareness resulted in the underutilization of spinal surgery choices, which influenced the overall demand for spinal implants and devices in the healthcare industry.

Category-wise Acumens

What Factors Contribute to the Increasing Demand for Spinal Fusion Devices?

According to VMR analyst, the spinal fusion device segment is estimated to dominate the Spinal Implants And Surgery Devices Market during the forecast period. The rising prevalence of spinal problems is a major factor in the domination of spinal fusion devices. As the population ages, diseases including degenerative disc degeneration, scoliosis, and spinal stenosis become more prevalent, demanding surgical intervention. This growing need for efficient treatment choices drives the need for spinal fusion surgeries, raising the market for related products.

Advancements in surgical procedures have a substantial impact on the growth of the spinal fusion device segment. Innovations like minimally invasive surgery (MIS) procedures improve surgical results by shortening recovery periods and lowering complications. The addition of robotic-assisted technology and advanced imaging systems improves the efficiency and effectiveness of spinal fusion surgery, making them more desirable to surgeons and patients.

Furthermore, the increased acceptance of minimally invasive techniques is another important factor driving market domination. Patients are increasingly choosing operations that promise a faster recovery and less postoperative pain. Spinal fusion devices designed for minimally invasive procedures are gaining popularity, leading to increased adoption rates. This trend not only improves patient satisfaction but also motivates healthcare providers to invest in innovative spinal fusion technologies.

How Does the Rising Prevalence of Spinal Disorders Drive the Adoption of Spinal Fusion & Fixation Technology?

The spinal fusion & fixation technology segment is estimated to hold the largest share of the Spinal Implants And Surgery Devices Market during the forecast period. The increased prevalence of spinal problems has a key role in the supremacy of spinal fusion and fixation technologies. As disorders like degenerative disc degeneration and spinal stenosis become more widespread, the need for appropriate surgical procedures grows. This trend drives healthcare providers to invest in improved fusion technologies that give dependable solutions for spine stabilization and pain relief, resulting in market growth.

The technological developments in spinal fusion treatments are another important factor contributing to the domination of this market. Robotic procedures, minimally invasive techniques, and improved implant designs all increase surgical outcomes and patient recovery times. These improvements not only improve the efficacy of spinal fusion procedures but also broaden the spectrum of treatment alternatives available to patients, reinforcing the segment's market leadership.

Furthermore, increased regulatory approvals for spinal fusion devices contribute significantly to the growth of this segment. The increasing number of FDA clearances for innovative spinal fixation systems stimulates businesses to innovate and launch cutting-edge solutions. This regulatory support promotes competition and market expansion by giving healthcare professionals access to a wider range of effective surgical solutions customized to patient needs.

Country/Region-wise Acumens

How Does the Demand for Spinal Implants in Asia Pacific Influence the Market?

The Asia Pacific region is estimated to exhibit the highest growth within the market during the forecast period. The growing aging population in the Asia Pacific is driving the demand for spinal surgery procedures. According to the United Nations Economic and Social Commission for Asia and the Pacific (ESCAP), the region's population aged 65 and more is predicted to double, from 651 million in 2023 to 1.3 billion in 2050. In Japan, the Ministry of Health, Labour, and Welfare states that spinal stenosis cases have climbed by 45% in the last five years, with over 250,000 spine procedures conducted each year.

Furthermore, rising road traffic accidents in developing Asian countries have a substantial impact on spinal trauma patients. According to the World Health Organization's Global Status Report on Road Safety, the Asia-Pacific region accounts for 60% of global road traffic mortality, with an estimated 2.3 million cases of serious spinal injuries reported each year. Between 2020 and 2023, China's National Bureau of Statistics reported a 28% increase in spine-related procedures resulting from vehicle accidents.

What Factor Contributes to the Dominance of the Market in North America?

North America is estimated to dominate the Spinal Implants And Surgery Devices Market during the forecast period. The increasing incidence of obesity in North America greatly contributes to spinal disorders that necessitate surgical intervention. According to the Centers for Disease Control and Prevention (CDC), 41.9% of adults in the United States were obese in 2022, with obesity being a significant risk factor for spinal illnesses. According to the National Institute of Health (NIH), obese people are 2.5 times more likely to have lower back problems that require surgery than people who are normal weight.

Furthermore, advanced healthcare infrastructure and high healthcare spending are driving market expansion in North America. According to the Centers for Medicare and Medicaid Services (CMS), U.S. healthcare spending reached USD 4.3 Trillion in 2023, with nearly USD 180 Billion set aside particularly for orthopedic and spine surgeries. According to data from the American Academy of Orthopedic Surgeons (AAOS), more than 1.62 million instrumented spinal procedures are performed annually in the United States, constituting the highest per capita rate internationally.

Competitive Landscape

The Spinal Implants And Surgery Devices Market has a moderate amount of competition, with both established and rising competitors aggressively innovating to gain market share. Companies are increasingly focused on technical developments, such as the development of minimally invasive surgical procedures and the incorporation of robotics and 3D printing in spinal surgery, to improve precision and patient outcomes.

Some of the prominent players operating in the Spinal Implants And Surgery Devices Market include:

Medtronic, DePuy Synthes (Johnson & Johnson), NuVasive, Inc., Stryker Corporation, Zimmer Biomet Holdings, Globus Medical, Abbott, RTI Surgical, Boston Scientific, SeaSpine Holdings Corporation.

Latest Developments:

In September 2024, Aurora Spine Corporation announced its participation in the 2024 North American Spine Society Annual Meeting, which will take place on September 25-28, 2024. The firm will display its unique technologies, including the SiLO(TM) TFX SI Fusion System and DEXA-C cervical interbody cage system, emphasizing improvements in individualized spinal treatment with patient-matched implants. This event demonstrates Aurora's dedication to revolutionizing spinal surgery with cutting-edge technology.

Spinal Implants And Surgery Devices Market, By Category

  • Type:
  • Open Surgery
  • Minimally Invasive Surgery
  • Product:
  • Spinal Fusion Devices
  • Spinal Biologics
  • Vertebral Compression Fracture Treatment Devices
  • Non-fusion Devices
  • Spinal Bone Growth Stimulators
  • Technology:
  • Spinal Fusion and Fixation Technology
  • Vertebral Compression Fracture Treatment
  • Motion Preservation Technologies
  • Spinal Decompression
  • Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL SPINAL IMPLANTS AND SURGERY DEVICES MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL SPINAL IMPLANTS AND SURGERY DEVICES MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL SPINAL IMPLANTS AND SURGERY DEVICES MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 Open Surgery
  • 5.3 Minimally Invasive Surgery

6 GLOBAL SPINAL IMPLANTS AND SURGERY DEVICES MARKET, BY PRODUCT

  • 6.1 Overview
  • 6.2 Spinal Fusion Devices
  • 6.3 Spinal Biologics
  • 6.4 Vertebral Compression Fracture Treatment Devices
  • 6.5 Non-fusion Devices
  • 6.6 Spinal Bone Growth Stimulators

7 GLOBAL SPINAL IMPLANTS AND SURGERY DEVICES MARKET, BY TECHNOLOGY

  • 7.1 Overview
  • 7.2 Spinal Fusion and Fixation Technology
  • 7.3 Vertebral Compression Fracture Treatment
  • 7.4 Motion Preservation Technologies
  • 7.5 Spinal Decompression

8 GLOBAL SPINAL IMPLANTS AND SURGERY DEVICES MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East and Africa

9 GLOBAL SPINAL IMPLANTS AND SURGERY DEVICES MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Medtronic
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 DePuy Synthes (Johnson & Johnson)
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 NuVasive, Inc.
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Stryker Corporation
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 Zimmer Biomet Holdings
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Globus Medical
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 Abbott
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 RTI Surgical
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Boston Scientific
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments
  • 10.10 SeaSpine Holdings Corporation
    • 10.10.1 Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Outlook
    • 10.10.4 Key Developments

11 Appendix

  • 11.1 Related Research